Kinetikos

Kinetikos is a digital health company founded in 2015 by Ricardo Matias and Luis Rodrigues. Based in Lisbon, Portugal, the firm is focused on developing a clinical decision support system to aid healthcare providers and patients in managing movement disorders, with an initial focus on Parkinson's disease. The development of the platform began in 2015, with its suite of digital tools for Parkinson's launching in Portugal in 2020. Ricardo Matias, a co-founder, also serves as an Associate Professor at the University of Lisbon's Department of Physics, with a core motivation to bridge the gap between movement technology's potential and its practical application in clinical settings.

The company's core offering is a digital platform that quantifies movement to provide clinical insights. It utilizes a mobile application, mKinetikos, which passively collects movement data from a patient's smartphone throughout the day. This data, along with patient-reported outcomes and medication adherence information, is processed in a secure cloud-based platform using computational biomechanics and machine learning. The system provides real-time, objective measurements of disease progression and symptoms without requiring wearable sensors. This enables clinicians to make more informed, data-driven decisions, monitor treatment efficacy, and intervene promptly by sending messages or adjusting medication through the platform.

Kinetikos targets its services toward healthcare providers, including neurologists and physiotherapists, pharmaceutical companies conducting clinical trials, and individual patients. For researchers and clinical trials, the Kinetikos Pro platform offers a more advanced motion analysis lab, providing in-depth kinematic data to complement investigations. While initially centered on Parkinson's, the company is expanding its objective assessment capabilities to other conditions affected by mobility, such as obesity, low back pain, and depression. The business model involves direct payment from patients for access and aims for adoption within national health systems, such as the NHS in the UK, where the company has established a base. Kinetikos has secured total funding of $1.11M over three rounds, including grants from the European Union.

Keywords: digital health, movement disorders, Parkinson's disease, clinical decision support, remote patient monitoring, healthtech, mobile health, biomechanics, machine learning, data-driven healthcare, medication adherence, real-world data, clinical trials, motion analysis, objective measurement, patient-reported outcomes, neurology, telemedicine, physiotherapy, continuous monitoring